Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis.

被引:0
|
作者
Raynauld, JP
Olszynski, WP
Goldsmith, CH
Torrance, GW
Bellamy, N
Polisson, R
Pericak, D
Walker, V
机构
[1] Univ Montreal, Montreal, PQ, Canada
[2] Univ Saskatchewan, Saskatoon, SK, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Univ Queensland, St Lucia, Qld 4067, Australia
[5] Genzyme Corp, Cambridge, MA USA
[6] Innovus Res Inc, Burlington, ON, Canada
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1218
引用
收藏
页码:S484 / S484
页数:1
相关论文
共 50 条
  • [1] Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis
    Raynauld, JP
    Goldsmith, CH
    Bellamy, N
    Torrance, GW
    Polisson, R
    Belovich, D
    Pericak, D
    Tugwell, P
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (02) : 111 - 119
  • [2] THE EFFECTIVENESS AND COST-EFFECTIVENESS OF HYLAN G-F 20 IN OSTEOARTHRITIS OF THE KNEE
    Kostyuk, A.
    Almadiyeva, A.
    Akanov, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A647 - A647
  • [3] Comparison of efficacy of hyaluronan and hylan G-F 20 in osteoarthritis.
    Sripada, P
    Pritchard, C
    Bankes, PF
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S296 - S296
  • [4] Hylan G-F 20 reduces the probability of progression to total knee replacement in knee osteoarthritis.
    Waddell, DD
    Bricker, DC
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S166 - S166
  • [5] Functional Improvement with Hylan G-F 20 in Patients with Knee Osteoarthritis
    Brander, Victoria A.
    Stadler, Teresa S.
    [J]. PHYSICIAN AND SPORTSMEDICINE, 2009, 37 (03): : 38 - 48
  • [6] A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis.
    Raynauld, JP
    Bellamy, N
    Goldsmith, C
    Tugwell, P
    Torrance, G
    Walker, V
    Schultz, M
    Pericak, D
    Band, P
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S340 - S340
  • [7] Prospective study of the safety and efficacy of hylan G-F 20 (Synvisc®) in patients with symptomatic ankle osteoarthritis.
    Witteveen, A. g. h.
    Giannini, S.
    Guido, G.
    Jerosch, J.
    Lohrer, H.
    van Dijk, C. N.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S676 - S676
  • [8] Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
    Webb, David
    Naidoo, Poobalan
    [J]. ORTHOPEDIC RESEARCH AND REVIEWS, 2018, 10 : 73 - 81
  • [9] A Randomized Controlled Trial of Hylan G-F 20 for the Treatment of Carpometacarpal Osteoarthritis.
    Mandl, Lisa A.
    Wolfe, Scott
    Daluiski, Aaron
    Hotchkiss, Robert N.
    Lyman, Stephen L.
    Katz, Jeffrey N.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S475 - S476
  • [10] Risk Factors for Knee Arthroplasty in Patients with Knee Osteoarthritis Treated with Hylan G-F 20
    Runa, Maria
    Ong, Kevin
    Lau, Edmund
    Daley, William
    Altman, Roy
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 679 - 679